$67.30
-0.27-0.4%
Last update: Nov 6, 5:46 PM
Royalty Pharma PLC (RPRX) Stock Price, Quote, News & History
RPRXNASDAQ
Novartis stock falls following Phase 3 clinical trial failures for del-desiran and pelacarsen, impacting Ionis and Royalty Pharma shares.
You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.
Other companies in Royalty Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Royalty Pharma has a consensus price target of $56.80.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $68.8 last updated November 6, 2026 at 5:46 PM EST.
There are no upcoming dividends for Royalty Pharma.
Royalty Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial...
